Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Dynamic contrast agent-enhanced perfusion magnetic resonance (MR) imaging provides physiologic information that complements the anatomic information available with conventional MR imaging. Analysis of dynamic data from perfusion MR imaging, based on tracer kinetic theory, yields quantitative estimates of cerebral blood volume that reflect the underlying microvasculature and angiogenesis. Perfusion MR imaging is a fast and robust imaging technique that is increasingly used as a research tool to help evaluate and understand intracranial disease processes and as a clinical tool to help diagnose, manage, and understand intracranial mass lesions. With the increasing number of applications of perfusion MR imaging, it is important to understand the principles underlying the technique. In this review, the essential underlying physics and methods of dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging are described. The clinical applications of cerebral blood volume maps obtained with perfusion MR imaging in the differential diagnosis of intracranial mass lesions, as well as the pitfalls and limitations of the technique, are discussed. Emphasis is on the clinical role of perfusion MR imaging in providing insight into the underlying pathophysiology of cerebral microcirculation.

[1]  M. Schabet Epidemiology of Primary CNS Lymphoma , 1999, Journal of Neuro-Oncology.

[2]  P. Wesseling,et al.  Angiogenesis in brain tumors; pathobiological and clinical aspects , 1997, Journal of Neuro-Oncology.

[3]  A. Falini,et al.  Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives , 1996, Journal of Neurology.

[4]  R. Herndon,et al.  Multiple sclerosis masquerading as a mass lesion , 2004, Neuroradiology.

[5]  R. Grossman,et al.  Magnetic resonance imaging determination of gliomatosis cerebri , 2004, Neuroradiology.

[6]  G. Johnson,et al.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. , 2001, AJNR. American journal of neuroradiology.

[7]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[8]  M. Essig,et al.  Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri , 2001, European Radiology.

[9]  J. Wardlaw,et al.  Systematic Review of Diffusion and Perfusion Imaging in Acute Ischemic Stroke , 2000, Stroke.

[10]  G Johnson,et al.  Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. , 2000, AJNR. American journal of neuroradiology.

[11]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[12]  H. Shimizu,et al.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.

[13]  G. Johnson,et al.  Dynamic susceptibility contrast MR imaging: Correlation of signal intensity changes with cerebral blood volume measurements , 2000, Journal of magnetic resonance imaging : JMRI.

[14]  D. Kondziolka,et al.  Distinguishing Recurrent Tumor and Radiation Necrosis with Positron Emission Tomography versus Stereotactic Biopsy , 2000, Stereotactic and Functional Neurosurgery.

[15]  A. King,et al.  Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. , 1999, Radiology.

[16]  W. Yuh,et al.  Clinical application of perfusion and diffusion MR imaging in acute ischemic stroke , 1999, Journal of magnetic resonance imaging : JMRI.

[17]  J. Porta‐Etessam,et al.  [Gliomatosis cerebri. MRI, SPECT and the study of pathology]. , 1999, Revista de neurologia.

[18]  G. Albers,et al.  Applications of diffusion–perfusion magnetic resonance imaging in acute ischemic stroke , 1999, Neurology.

[19]  J L Tanabe,et al.  MR perfusion imaging in human brain using the UNFAIR technique , 1999, Journal of magnetic resonance imaging : JMRI.

[20]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[21]  M Takahashi,et al.  Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.

[22]  M Takahashi,et al.  Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. , 1999, Journal of computer assisted tomography.

[23]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[24]  M. Castillo,et al.  Proton MR spectroscopy of common brain tumors. , 1998, Neuroimaging clinics of North America.

[25]  A M Peters,et al.  Fundamentals of tracer kinetics for radiologists. , 1998, The British journal of radiology.

[26]  P. Black,et al.  Angiostatin suppresses malignant glioma growth in vivo. , 1998, Cancer research.

[27]  M. Taphoorn,et al.  Bilateral temporal lobe necrosis after radiotherapy: Confounding SPECT results , 1998, Neurology.

[28]  J C Gore,et al.  Asymmetric spin‐echo imaging of magnetically inhomogeneous systems: Theory, experiment, and numerical studies , 1998, Magnetic resonance in medicine.

[29]  M A Goldberg,et al.  Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. , 1998, Radiology.

[30]  J. Dichgans,et al.  Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma , 1998, Acta neurologica Scandinavica.

[31]  W. Powers,et al.  Magnetic resonance imaging in acute stroke , 1998, Neurology.

[32]  B. Drayer,et al.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.

[33]  M. Reiser,et al.  Regional relative blood volume MR maps of meningiomas before and after partial embolization. , 1998, Journal of computer assisted tomography.

[34]  Jie Zheng,et al.  Comparison of inversion recovery asymmetrical spin‐echo EPI and gradient‐echo EPI for brain motor activation study , 1997, Journal of magnetic resonance imaging : JMRI.

[35]  J. Folkman,et al.  Suppression of tumor growth with recombinant murine angiostatin. , 1997, Biochemical and biophysical research communications.

[36]  J A Frank,et al.  Effect of magnetization transfer on the measurement of cerebral blood flow using steady‐state arterial spin tagging approaches: A theoretical investigation , 1997, Magnetic resonance in medicine.

[37]  M. Reni,et al.  Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[39]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[40]  J. Schoenen,et al.  Gliomatosis cerebri: clinical, radiological and pathological report of a case with a stroke-like onset. , 1996, Acta neurologica Belgica.

[41]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.

[42]  K Suzuki,et al.  Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. , 1996, AJNR. American journal of neuroradiology.

[43]  S. Higano,et al.  MR imaging of multiple sclerosis simulating brain tumor. , 1996, Clinical imaging.

[44]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[45]  M. Castillo,et al.  Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[46]  J. Folkman Clinical Applications of Research on Angiogenesis , 1995 .

[47]  G. Criscuolo,et al.  Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. , 1995, Journal of neurosurgery.

[48]  Seong-Gi Kim Quantification of relative cerebral blood flow change by flow‐sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping , 1995, Magnetic resonance in medicine.

[49]  W. Olivero,et al.  The use of PET in evaluating patients with primary brain tumours: is it useful? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[50]  K. Plate,et al.  Vascular morphology and angiogenesis in glial tumors. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[51]  W. J. Lorenz,et al.  Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. , 1994, Radiology.

[52]  G. Criscuolo,et al.  Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. , 1994, Journal of neurosurgery.

[53]  Effects of Gd‐DTPA after Osmotic BBB Disruption in a Rodent Model: Toxicity and MR Findings , 1994, Journal of computer assisted tomography.

[54]  R R Edelman,et al.  Echo-planar MR imaging. , 1994, Radiology.

[55]  R L DeLaPaz,et al.  Echo-planar imaging. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.

[56]  A. Nobre,et al.  Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. , 1994, Radiology.

[57]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[58]  D. Larson,et al.  Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco , 1994, Cancer.

[59]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[60]  P. Panegyres,et al.  Delayed cerebral radiation necrosis. , 1994, The Quarterly journal of medicine.

[61]  William Arbuthnot Sir Lane,et al.  Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. , 1994, Cold Spring Harbor symposia on quantitative biology.

[62]  Douglas C. Miller,et al.  Demyelinating Disease Versus Tumor in Surgical Neuropathology: Clues to a Correct Pathological Diagnosis , 1993, The American journal of surgical pathology.

[63]  Donald S. Williams,et al.  Measurement of rat brain perfusion by NMR using spin labeling of arterial water: In vivo determination of the degree of spin labeling , 1993, Magnetic resonance in medicine.

[64]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[65]  J. Kepes,et al.  Large focal tumor‐like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients , 1993, Annals of neurology.

[66]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[67]  D. Podoloff,et al.  Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.

[68]  H Okazaki,et al.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. , 1991, Radiology.

[69]  B. Miller A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[70]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[71]  W P Dillon,et al.  Radiation injury of the brain. , 1991, AJNR. American journal of neuroradiology.

[72]  Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination. , 1990, AJNR. American journal of neuroradiology.

[73]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[74]  K. Welch,et al.  Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonance. , 1990, Stroke.

[75]  G. Bydder,et al.  Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in In vivo human spectroscopy , 1989, NMR in biomedicine.

[76]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[77]  J. Ackerman,et al.  Multicompartment analysis of blood flow and tissue perfusion employing D2O as a freely diffusible tracer: A novel deuterium NMR technique demonstrated via application with murine RIF‐1 tumors , 1988, Magnetic resonance in medicine.

[78]  P. Burger,et al.  Increasing incidence of primary brain lymphoma in the US , 1988, Cancer.

[79]  B. Rosen,et al.  Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.

[80]  C. Kufta,et al.  Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. , 1987, AJR. American journal of roentgenology.

[81]  B A Kall,et al.  Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. , 1987, Mayo Clinic proceedings.

[82]  Hunter Sb,et al.  Multiple sclerosis mimicking primary brain tumor. , 1987 .

[83]  D. Roberts,et al.  CT‐guided stereotactic biopsy of intracranial lesions: Correlation between core biopsy and aspiration smear , 1986, Diagnostic cytopathology.

[84]  P. Burger,et al.  Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. , 1986, Seminars in oncology.

[85]  T. H. Newton,et al.  Brain radiation lesions: MR imaging. , 1986, Radiology.

[86]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[87]  J. Cervós-Navarro,et al.  Gliomatosis cerebri: clinical and histological findings. , 1985, Clinical neuropathology.

[88]  G. Johnson,et al.  The limitations of NMR recalled-echo imaging techniques , 1985 .

[89]  V M Runge,et al.  The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. , 1985, Magnetic resonance imaging.

[90]  Willems Jg,et al.  Accuracy of cytologic diagnosis of central nervous system neoplasms in sterotactic biopsies. , 1984 .

[91]  L. Axel Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.

[92]  P. Burger,et al.  The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases , 1979, Cancer.

[93]  D. Long,et al.  Capillary ultrastructure in human metastatic brain tumors. , 1979, Journal of neurosurgery.

[94]  P. Mansfield Multi-planar image formation using NMR spin echoes , 1977 .

[95]  Pekary Ae,et al.  Nuclear magnetic resonance studies of histone IV solution conformation. , 1975 .